Dependence of heart rate variability on indicators of type 1 diabetes mellitus control.

Authors

DOI:

https://doi.org/10.26641/2307-0404.2020.1.200406

Keywords:

diabetes mellitus type 1, heart rate variability, control markers

Abstract

The aim of our study was to evaluate the influence of the main indicators of type 1 diabetes mellitus (T1DM) control on heart rate variability (HRV). We examined 62 patients at the age of 18-45 years with an average T1DM duration of 11.0 (5.0; 18.0) years. HRV in the time and frequency range was evaluated by analyzing a 24-hour Holter electrocardiogram (ECG). The following laboratory parameters were used as markers of course and compensation of T1DM: C-peptide, HbA1c, blood creatinine, albuminuria (AU), estimated glomerular filtration rate (eGFR) by CKD-EPI formula. In addition, the maximum and minimum blood glucose levels and the blood glucose range (maximum minus minimum blood glucose values) were conducted by continuous glucose monitoring system iPro2 (Medtronic MiniMed, USA). The daily monitoring of electrocardiogram (ECG) was made in parallel with long term monitoring of blood glucose. Echocardiography in all patients was performed to exclude organic heart disease and the possibility of its influence on HRV. Poor control of T1DM negatively influences HRV through decrease in both frequency and time characteristics. The blood glucose range can be an additional negative factor for cardiovascular system in T1DM patients, regardless of HbA1c, whereas it positively correlates with HRV- relative hypersympathicotonia markers: LF/HF 24-h, ρ=0.43 (p<0.05), LF/HF day ρ=0.37 (p<0.05), ρ=0.38 LF/HF night. Diabetic nephropathy is another factor of cardiovascular disease progression in T1DM, since its criteria have reliably negative (for eGFR) and positive (for AU) correlations of mean force with all HRV characteristics. Selected markers of T1DM control cause 45, 73% of variance in HRV, mainly affecting TP 24-h, TP daytime, VLF 24-h, VLF daytime. Reduction of these frequency HRV characteristics may indicate autonomic neuropathy in patients with poor control of T1DM.

Author Biographies

N. O. Pertseva

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Endocrinology
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

O. V. Gurzhiy

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Endocrinology
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

K. I. Moshenets

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Endocrinology
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

References

Moskalenko VF, Gulchiy OP, Colubchikov MV. [Biostatistika]. Kyiv: Knigaplus; 2009 p. 184. Ukrainian.

Lytovskyi MN. [Statistical, visual and morpho­logical aspects of the diabetes effect on the cardiovascular system]. Naukovyi visnyk Uzhogodskogo universytetu, Seriia: Medytsyna; 2017;55(1):168-77. Ukrainian.

[Order of HM Ukraine from 29.12.2014 N 1021. The unified clinical protocols of primary, secondary (spe­cialized) and tertiary (highly specialized) medical care. Type 1 diabetes in young people and adults ]. Kyiv; 2014. Ukrainian.

Agashe S, Petak S. Cardiac Autonomic Neuro­pathy in Diabetes Mellitus. Methodist Debakey Cardio­vasc J. 2018;14(4):251-6. doi: doi.org/10.14797/mdcj-14-4-251

Pop-Busui R, Braffett BH, Zinman B, Martin C, White NH, Herman WH, Genuth S, Gubitosi-Klug R. DCCT/EDIC Research Group. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epi­demio­logy of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2017;40(1):94-100. doi: https://doi.org/10.2337/dc16-1397

Cygankiewicz I, Zareba W. Heart rate variability. Handb Clin Neurol. 2013;117:379-93. doi: https://doi.org/10.1016/B978-0-444-53491-0.00031-6

Madonna R, Balistreri CR, Geng YJ, De Caterina R. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches. Vascul Pharmacol. 2017;90:1-7. doi: https://doi.org/10.1016/j.vph.2017.01.004

Fisher VL, Tahrani AA. Cardiac autonomic neu­ropathy in patients with diabetes mellitus: Current perspectives. Diabetes Metab Syndr Obes. 2017;10:419-34. doi: https://doi.org/10.2147/DMSO.S129797

Bishop SA, Dech RT, Guzik P, Neary JP. Heart rate variability and implication for sport concussion. Clin Physiol Funct Imaging. 2018;38(5):733-42. doi: https://doi.org/10.1111/cpf.12487

Hillebrand S, Gast KB, de Mutsert R, Swen­ne CA, Jukema JW, Middeldorp S, Rosendaal FR, Dekkers OM. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013;15(5) :742-9. doi: https://doi.org/10.1093/europace/eus341

Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD. Molecular mechanisms of cardiac patho­logy in diabetes – Experimental insights. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;1864(5 Part B):1949-59. doi: https://doi.org/10.1016/j.bbadis.2017.10.035

Shaffer F, and Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017;5:258. doi: https://doi.org/10.3389/fpubh.2017.00258

Spallone V. Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet. Diabetes Metab J. 2019;43(1):3-30. doi: https://doi.org/10.4093/dmj.2018.0259

American Diabetes Assosiation: Standards of Medical Care in Diabetes –2016. Diabetes Care. 2016;39(1). doi: https://doi.org/10.2337/dc16-S003

Silva LE, Silva CA, Salgado HC, Fazan RJr. The role of sympathetic and vagal cardiac control on complexity of heart rate dynamics. Am J Physiol Heart Circ Physiol. 2017;312(3):H469-77. doi: https://doi.org/10.1152/ajpheart.00507.2016

Saberzadeh-Ardestani B, Karamzadeh R, Basi­ri M, Hajizadeh-Saffar E, Farhadi A, Shapiro AMJ, Taha­mtani Y, Baharvand H. Type 1 diabetes mellitus: cellular and mole­cular pathophysiology at a glance. Cell J. 2018;20(3):294-301. doi: https://doi.org/10.22074/cellj.2018.5513

Published

2020-04-09

How to Cite

1.
Pertseva NO, Gurzhiy OV, Moshenets KI. Dependence of heart rate variability on indicators of type 1 diabetes mellitus control. Med. perspekt. [Internet]. 2020Apr.9 [cited 2024Nov.5];25(1):88-95. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/200406

Issue

Section

CLINICAL MEDICINE